Skip to main content

STERIS plc (STE) Stock

STERIS plc Stock Details, Movements and Public Alerts

Stock Details

STERIS plc (STE), a prominent company in the life sciences sector within the orthopedic, prosthetic & surgical appliances & supplies industry, is based in USA and primarily trades on the NYSE.Currently, the stock is trading at $228.03. Over the past 52 weeks, it has ranged between $199.99 and $252.20. This places the current price at 90.4% of its 52-week high and 14.0% above its 52-week low. Recent trading volume was recorded at 74,163. The International Securities Identification Number (ISIN) for this stock is US8589121081.

52-Week High

$252.20

-9.58% from high

52-Week Low

$199.99

+14.02% from low

Avg Daily Volume

74,163

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

39.00

Above market average

Forward P/E

23.81

Earnings expected to grow

PEG Ratio

1.94

Reasonably valued

Price to Book

3.56

EV/EBITDA

18.78

EPS (TTM)

$6.16

Price to Sales

4.33

Beta

0.94

Less volatile than market

How is STE valued relative to its earnings and growth?
STERIS plc trades at a P/E ratio of 39.00, which is above the market average of approximately 20. This premium valuation suggests investors expect above-average growth or the company has competitive advantages justifying the higher multiple. Looking ahead, the forward P/E of 23.81 is lower than the current P/E, indicating analysts expect earnings to grow over the next year. The PEG ratio of 1.94 indicates reasonable value when growth is considered.
What is STE's risk profile compared to the market?
With a beta of 0.94, STERIS plc is less volatile than the overall market. This means when the market moves up or down by 10%, this stock typically moves less than 10% in the same direction. Lower beta stocks are often preferred by conservative investors seeking stability. The price-to-book ratio of 3.56 shows investors value the company above its book value, which often reflects intangible assets or growth prospects.

Performance & Growth

Profit Margin

11.30%

Operating Margin

20.00%

Return on Equity

9.46%

Return on Assets

5.82%

Revenue Growth (YoY)

4.30%

Earnings Growth (YoY)

23.80%

How profitable and efficient is STE's business model?
STERIS plc achieves a profit margin of 11.30%, meaning it retains $11.30 from every $100 in revenue after all expenses. This represents a solid margin typical of well-run businesses, showing the company can effectively balance revenue generation with cost control. The operating margin of 20.00% reveals how efficiently the company runs its core business operations before interest and taxes. With ROE at 9.46% and ROA at 5.82%, the company achieves moderate returns on invested capital.
What are STE's recent growth trends?
STERIS plc's revenue grew by 4.30% year-over-year, showing steady progress in growing the business. This positive trajectory indicates the company maintains competitive positioning in its markets. Earnings increased by 23.80% year-over-year, outpacing revenue growth through improved margins. These growth metrics should be evaluated against ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES industry averages for proper context.

Dividend Information

Dividend Per Share

$2.23

Dividend Yield

0.95%

Ex-Dividend Date

6/10/2025

Dividend Date

6/26/2025

What dividend income can investors expect from STE?
STERIS plc offers a dividend yield of 0.95%, paying $2.23 per share annually. This modest yield below 2% suggests the company prioritizes growth investments over current income. While the dividend provides some return, investors are likely attracted more by capital appreciation potential than income generation. To receive the next dividend, shares must be purchased before the ex-dividend date of 6/10/2025.
How reliable is STE's dividend for long-term investors?
The dividend sustainability can be assessed through the payout ratio - STERIS plc pays $2.23 per share in dividends against earnings of $6.16 per share, resulting in a payout ratio of 36.20%. This balanced payout between 30-60% suggests a sustainable dividend policy that allows both shareholder returns and business reinvestment. The dividend appears well-covered by earnings. The next dividend payment is scheduled for 6/26/2025.

Company Size & Market

Market Cap

$23.63B

Shares Outstanding

98.37M

Book Value/Share

$67.17

Asset Type

Common Stock

What is STE's market capitalization and position?
STERIS plc has a market capitalization of $23.63B, classifying it as a large-cap stock ($10B-$200B). Large-caps are typically industry leaders with established business models, offering a balance of stability and growth potential. They often provide dividend income and are core holdings in institutional portfolios. With 98.37M shares outstanding, the company's ownership is relatively concentrated. As a participant in the ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES industry, it competes with other firms in this sector.
How does STE's price compare to its book value?
STERIS plc's book value per share is $67.17, while the current stock price is $228.03, resulting in a price-to-book (P/B) ratio of 3.39. This high P/B ratio indicates significant intangible assets, strong brand value, or high growth expectations. Technology and consumer brand companies often trade at elevated P/B ratios due to intellectual property and competitive advantages not reflected on the balance sheet. As a common stock, this represents equity ownership with voting rights.

Analyst Ratings

Analyst Target Price

$263.10

15.38% upside potential

Analyst Recommendations

Strong Buy

2

Buy

3

Hold

5

Sell

0

Strong Sell

0

How reliable are analyst predictions for STE?
10 analysts cover STE with 50% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The mixed views reflect uncertainty about the outlook. The consensus target of $263.10 implies 15.4% upside, but targets are often adjusted to follow price moves rather than predict them.
What is the Wall Street consensus on STE?
Current analyst recommendations:2 Strong Buy, 3 Buy, 5 Hold, 00The neutral stance suggests uncertainty or fair valuation at current levels.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.

Fundamentals last updated: Jul 1, 2025, 03:47 AM

Technical Indicators

What does STE's RSI value tell investors?
RSI data is not available for this stock.
How should traders interpret STE's MACD and moving average crossovers?
MACD and moving average data are not available for this stock.

No technical indicators available yet.

Active Alerts

No active alerts for this stock.

Be the first to set up an alert for STE and get notified when the price changes.

Stay Ahead of the Market with STERIS plc Alerts

Set up price alerts for STERIS plc and get notified instantly when the price hits your target. Never miss an important price movement again.